PAION

Companies announce agreement for technology used in clinical trials of stroke treatment

Published in Law and Health Weekly, December 11th, 2004

PAION and Philips announced that Philips brain perfusion CT software package would be used in conjunction with PAION's investigational drug Desmoteplase in clinical trials.

PAION said it chose the Philips-exclusive software to assist in the determination of safety and effectiveness of Desmoteplase in the treatment of stroke patients.

According to PAION, the software displays summary maps, which make it possible to distinguish between still-viable and non-viable infarcted tissue. It also includes quantitative color maps of cerebral blood flow, cerebral blood volume, mean transit time and time-to-peak. These provide valuable clinical information for...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2004-12-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry